Both candidates are designed to move beyond single-pathway GLP-1 therapy, but they take very different routes: CagriSema combines an amylin analog with semaglutide, while Retatrutide compresses GIP, GLP-1, and glucagon agonism into one investigational peptide
Self-administering peptides without medical supervision carries real risks, including product quality issues, incorrect dosing, and unknown interactions with other medications
With her professional expertise, Janet will tailor your B12 injection protocol to your specific health needs and goals
The indirect costs of IC/BPS, including time away from work and lost productivity while working, are particularly significant since the condition primarily affects working age adults, and especially women aged 25-50 years
Plus, discover natural strategies to reduce hormonal imbalances, stress, and anxiety